ImmunityBio, Inc. IBRX Weighted Average Exercise Price of Vested and Expected to Vest Options
Weighted Average Exercise Price of Vested and Expected to Vest Options at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s weighted average exercise price of vested and expected to vest options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s weighted average exercise price of vested and expected to vest options?
- ImmunityBio, Inc. (IBRX) reported weighted average exercise price of vested and expected to vest options of $5.83 in Q1 2026.
- How has ImmunityBio, Inc.'s weighted average exercise price of vested and expected to vest options changed year-over-year?
- ImmunityBio, Inc.'s weighted average exercise price of vested and expected to vest options decreased by 35.8% year-over-year, from $9.08 to $5.83.